Latest Revenue Growth News

Bank of Queensland reports a 12% rise in cash earnings for FY25 despite a 53% drop in statutory profit due to one-off impairments and restructuring. The bank’s strategic pivot towards commercial lending and digital transformation underpins improved operational performance and shareholder returns.

Bank of Queensland reported a 4% increase in revenues to $1.668 billion for FY25, yet profits after tax fell sharply by 53% to $133 million. Despite the profit decline, the bank declared a fully franked 20 cent dividend for the full year.

Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.

BKI Investment Company Limited reported a steady financial performance for FY2025, raising its ordinary dividend by 1% to 7.90 cents per share. The company remains confident in maintaining dividends in FY2026, supported by a diversified portfolio and positive economic outlook.

333D Ltd reports a fifth consecutive quarter of revenue growth, secures $1 million in fresh capital, and expands its blockchain healthcare initiatives while building a strategic Bitcoin treasury.

Aussie Broadband reported robust FY25 results with nearly $1.2 billion revenue and signed a transformative six-year wholesale agreement, setting the stage for ambitious growth through FY28.

ReNerve Limited has achieved its first commercial sales of the EmpliQ™ amniotic tissue products, marking a significant step in its transition from R&D to commercialisation. The EmpliQ™ range complements its existing nerve repair solutions and targets a growing global wound care market.

Resonance Health reveals a robust growth strategy targeting $17 million revenue by FY26, powered by AI-enhanced medical imaging and global clinical trial services expansion.

Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.

DroneShield’s DroneSentry counterdrone system has earned official recognition from the UK’s National Protective Security Authority, boosting its credibility and market potential amid rising drone threats.

SSH Group has reported a robust 17% increase in revenue for the September quarter, underscoring strong operational performance at its Mt Fisher Gold Project.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.